Clarifies coverage requirements for epinephrine auto-injectors under New York insurance law.
This bill amends the insurance law to clarify that health insurance plans must cover at least two medically necessary epinephrine auto-injector devices for emergency treatment of life-threatening allergic reactions. Such coverage may be subject to the plan's annual deductible, except for preventive care services. The bill also caps the out-of-pocket cost for these devices at $100 annually, regardless of the insured's deductible, copayment, coinsurance, or other cost-sharing requirements.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.